RxDoctor Payments Data

Blake Bowden, MD

Orthopaedic Surgery · Mobile, ALNPI 1073960704

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.9%), grants and food and beverage — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Globus Medical at 39.1% of the total. Reporting peaked in 2021 at $9,499 and has fallen 75.0% since, to $2,376 in 2025.

$22,314in general payments, 2019–2025

Across 101 payments — averaging $220.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$9K
  • Alphatec Spine, Inc$4K
  • Innovasis Inc$3K
  • Zavation Medical Products, LLC$2K
  • Mirus, LLC$916
  • Medical Device Business Services, Inc.$585
  • plus $3K from 33 others

What the payments were for

  • Consulting fees$1,0225%
  • Speaking & faculty fees$310%
  • Grants$6,80030%
  • Travel & lodging$9,35542%
  • Food & beverage$4,52020%
  • Education$5853%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,314 in reported general payments places this provider in the 85th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$127,584
Medicare patients
326
Services billed
1,117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol1,047$7,180
Gabapentin1,185$6,878
Meloxicam568$1,723
Methylprednisolone140$1,273
Cyclobenzaprine Hcl113$1,065
Pregabalin37$708
Tizanidine Hcl54$656
Diclofenac Sodium40$600
Celecoxib14$575
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$282
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$215
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$118
Tramadol Hcl15$79
Ondansetron Hcl11$45
Lorazepam23$24

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →